Literature DB >> 19190147

Incident invasive breast cancer, geographic location of residence, and reported average time spent outside.

Amy E Millen1, Mary Pettinger, Jo L Freudenheim, Robert D Langer, Carol A Rosenberg, Yasmin Mossavar-Rahmani, Christine M Duffy, Dorothy S Lane, Anne McTiernan, Lewis H Kuller, Ana Maria Lopez, Jean Wactawski-Wende.   

Abstract

There have been reports of greater breast cancer incidence and mortality at northern compared with southern latitudes postulated to be related to vitamin D exposure. Among 71,662 participants in the Women's Health Initiative Observational Study (WHIOS) free of cancer at baseline (1993-1998), associations were explored between incident invasive postmenopausal breast cancer (n = 2,535), over approximately 8.6 years follow-up, and the following: (a) region of residence at birth, age 15 years, age 35 years; (b) region of residence at WHIOS baseline; and (c) clinic center solar irradiance. Hazard ratios and 95% confidence intervals (CI) for breast cancer were estimated after adjustment for individual level confounders. There was no difference in breast cancer risk by region of earlier life, baseline residence, or solar irradiance measured in Langelys (gm-cal) per cm(2). There was an observed 15% decreased risk among women residing in areas of low versus high solar irradiance measured in Watts per m(2) (95% CI, 2-26%). However, the associated P(trend) of 0.20 was not significant. Conversely, women who reported spending on average <30 minutes versus >2 hours outside in daylight year round at WHIOS year 4 follow-up (n = 46,926), had a 20% (95% CI, 2-41%; P(trend) = 0.001) increased risk of breast cancer. In conclusion, region of residence and geographic solar irradiance are not consistently related to risk of breast cancer and may not be sufficient proxy measures for sunlight/vitamin D exposure. The observed association between time spent outside and breast cancer risk support the hypothesis that vitamin D may protect against breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190147     DOI: 10.1158/1055-9965.EPI-08-0652

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  22 in total

1.  Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study.

Authors:  Lawrence S Engel; Irene Orlow; Camelia S Sima; Jaya Satagopan; Urvi Mujumdar; Pampa Roy; Sarah Yoo; Dale P Sandler; Michael C Alavanja
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-14       Impact factor: 4.254

2.  The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.

Authors:  Marian L Neuhouser; JoAnn E Manson; Amy Millen; Mary Pettinger; Karen Margolis; Elizabeth T Jacobs; James M Shikany; Mara Vitolins; Lucile Adams-Campbell; Simin Liu; Erin LeBlanc; Karen C Johnson; Jean Wactawski-Wende
Journal:  Am J Epidemiol       Date:  2012-02-22       Impact factor: 4.897

3.  Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial.

Authors:  Amy E Millen; Jean Wactawski-Wende; Mary Pettinger; Michal L Melamed; Frances A Tylavsky; Simin Liu; John Robbins; Andrea Z LaCroix; Meryl S LeBoff; Rebecca D Jackson
Journal:  Am J Clin Nutr       Date:  2010-03-10       Impact factor: 7.045

4.  Vitamin D intake from foods and supplements and depressive symptoms in a diverse population of older women.

Authors:  Elizabeth R Bertone-Johnson; Sally I Powers; Leslie Spangler; Robert L Brunner; Yvonne L Michael; Joseph C Larson; Amy E Millen; Maria N Bueche; Elena Salmoirago-Blotcher; Simin Liu; Sylvia Wassertheil-Smoller; Judith K Ockene; Ira Ockene; JoAnn E Manson
Journal:  Am J Clin Nutr       Date:  2011-08-24       Impact factor: 7.045

5.  Dietary vitamin D and calcium intake and mammographic density in postmenopausal women.

Authors:  Elizabeth R Bertone-Johnson; Rowan T Chlebowski; Joann E Manson; Jean Wactawski-Wende; Aaron K Aragaki; Rulla M Tamimi; Kathryn M Rexrode; Cynthia A Thomson; Thomas E Rohan; Jennifer D Peck; Etta D Pisano; Christopher F Martin; Gloria Sarto; Anne McTiernan
Journal:  Menopause       Date:  2010 Nov-Dec       Impact factor: 2.953

6.  Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.

Authors:  Laura L Reimers; Katherine D Crew; Patrick T Bradshaw; Regina M Santella; Susan E Steck; Iryna Sirosh; Mary Beth Terry; Dawn L Hershman; Elizabeth Shane; Serge Cremers; Elzbieta Dworakowski; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon
Journal:  Cancer Causes Control       Date:  2014-11-25       Impact factor: 2.506

7.  Periodontal Disease and Breast Cancer-Response.

Authors:  Jo L Freudenheim; Amy E Millen; Jean Wactawski-Wende
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05       Impact factor: 4.254

8.  Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative.

Authors:  Christina A Gamba; Susan M Swetter; Marcia L Stefanick; Jessica Kubo; Manisha Desai; Katrina M Spaunhurst; Animesh A Sinha; Maryam M Asgari; Susan Sturgeon; Jean Y Tang
Journal:  Cancer       Date:  2013-03-11       Impact factor: 6.860

9.  Prospective study of ultraviolet radiation exposure and risk of breast cancer in the United States.

Authors:  Rachel D Zamoiski; D Michal Freedman; Martha S Linet; Cari M Kitahara; Wayne Liu; Elizabeth K Cahoon
Journal:  Environ Res       Date:  2016-08-18       Impact factor: 6.498

10.  Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational study.

Authors:  Mary Pressler; Carol A Rosenberg; Benjamin A Derman; Philip Greenland; Janardan Khandekar; Rebecca J Rodabough; Anne McTiernan; Michael S Simon
Journal:  Breast Cancer Res Treat       Date:  2013-06-13       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.